Remote Monitoring To Identify Worsening Heart Failure The REMOTI-HF Randomized Clinical Trial
REMOTI-HF
1 other identifier
interventional
270
0 countries
N/A
Brief Summary
Heart failure, characterized by high mortality and morbidity rates, frequent hospital admissions, and prolonged stays in cardiology wards, significantly impacts patients' quality of life. The REMOTI-HF is a single-center randomized controlled trial designed to assess the impact of remote monitoring, utilizing the HeartLogic and TriageHF algorithms, in patients with heart failure with implantable cardioverter defibrillator or cardiac resynchronization therapy. The primary endpoints include mortality, hospital admissions related to heart failure, and visits for worsening heart failure. Moreover, we will explore the full capabilities of these algorithms, by analysing the association of physical activity, measured by the devices, with the same key outcomes. Additionally, the research will explore the relationship between the absolute values provided by the algorithms and NT-proBNP values.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable heart-failure
Started Jul 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 15, 2024
CompletedFirst Posted
Study publicly available on registry
May 21, 2024
CompletedStudy Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedMay 21, 2024
May 1, 2024
7 months
May 15, 2024
May 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary Composite Outcome
All-cause mortality, Hospital Admission for Heart Failure, Ventricular Arrhythmias and Worsening Heart Failure as defined in the secondary outcome area.
2 years
Secondary Outcomes (5)
All-cause mortality
2 years
Hospital admission for Heart Failure
2 years
Worsening Heart failure
2 eras
Ventricular Arrhythmias
2 years
Atrial Arrhytmias
2 years
Study Arms (2)
Interventional group
EXPERIMENTALIn this group the respective algorithm will be activated and alerts will be sent according to its design
Control Group
NO INTERVENTIONThe algorithm will not be activated and follow-up will continue as if the patient was not included in the study.
Interventions
Activation of the HeartLogic and TriageHF algorithms for implantable devices and correctly act according to its design
Eligibility Criteria
You may qualify if:
- Possession of an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT) device that is compatible with the HeartLogic or TriageHF algorithms.
- Left ventricular ejection fraction at the time of device implantation must be equal to or less than 35%.
You may not qualify if:
- Younger than 18 years old or older than 85 years old.
- Unable to be contacted when out of the hospital.
- Presence of severe cognitive impairment.
- Currently on the heart transplant waiting list
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gonçalo Batista, MD
ULS Coimbra
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Patients will not know whether the algorithms was activated or not at the beginning of the study. However, if a contact with the patient is made due to the algorithm, the patient will then understand they are not on the control group. The person responsible for contacts will also know if an individual patient is on the control or intervention group.
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Cardiology Resident
Study Record Dates
First Submitted
May 15, 2024
First Posted
May 21, 2024
Study Start
July 1, 2024
Primary Completion
February 1, 2025
Study Completion (Estimated)
July 1, 2026
Last Updated
May 21, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share